Efficacy of autologous platelet rich plasma on morphea: A comparative clinical and ultrasonographic follow up study
Not Applicable
- Conditions
- Skin and Connective Tissue Diseases
- Registration Number
- PACTR202301820107782
- Lead Sponsor
- Dermatology department
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Patients with acute or chronic morphea
Exclusion Criteria
1- Patients using anti-coagulation therapy, non-steroidal anti-inflammatory drugs,
2- patients having other connective tissue autoimmune diseases, chronic liver disease, blood diseases, critical thrombocytopenia or HIV and uncontrolled diabetes.
3- Patients who received topical or systemic treatment for morphea in the last month.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical cosmetic improvement using the Localized Scleroderma Assessment Tool (LoSCAT).
- Secondary Outcome Measures
Name Time Method ltrasonographic improvement using high frequency linear transducer machine